Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In Phase 3 TRIUMPH-1 data, dysesthesia occurred in 5.1%, 12.3%, and 12.5% of participants taking retatrutide 4 mg, 9 mg, and 12 mg, compared with 0.9% of participants receiving placebo
The program offers personalized GLP-1 therapy alongside unlimited check-ins with medical professionals who tailor your nutrition and exercise plans as you progress
They need this information to provide you with the best possible coordinated care
Journal reference: Emptage, I., Kozmr, S., Cobham-Wilson, A., Sousa, B., Sugden, K., Wheeler, L., Llewellyn, C., Makaronidis, J., Bulik, C., Solmi, F
US$ 25.48
US$ 29.62
US$ 22.88
US$ 20.75
US$ 25.87
US$ 21.25
US$ 29.72
